Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market

Eli Lilly escalates fight against black market weight-loss medicines

The drug company said Wednesday that it planned to file lawsuits against US businesses that sell retatrutide products illegally, and it’s asking regulators to do more to rein in the illicit market